Chineo
Beijing
About Chineo
Chineo is a CAR-T immune cell therapy service provider.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $90.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2021)
- Website: chineomed.com
- Phone: 010-87520529
Industries & Categories
Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/chineo-57701 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.